Delivery Order SPE2DB24D2217-SPE2DB24FJVRS

Award Date 8/28/24
Potential Completion Date 9/19/24
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,092.24, is for the delivery of LONSURF 15 MG-6.14 MG tablets. The contract has an ultimate completion date of April 22, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,124.17, is for the supply of the drug LONSURF 15 MG-6.14 MG TABLET 40S. The contract has an ultimate completion date of April 4, 2025 and a firm fixed price pricing type. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a $999,999,999 Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LONSURF 20 MG-8.19 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $10,173.33. The period of performance extends to July 7, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp...
This is a $7,685.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 15 MG-6.14 MG tablets, which are used for medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LONSURF 20 MG-8.19 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $12,712.48 and a period of performance ending on July 23, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $4,835.01 firm fixed price delivery order is for the supply of 4564118881 - LONSURF 15 MG-6.14 MG TABLET 40S, a pharmaceutical product. The contract has an ultimate completion date of April 19, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication LONSURF 15 MG-6.14 MG TABLET 40S. The contract has a ceiling value of $5,124.17 and a period of performance ending on July 23, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, identified as SPE2DB22D3004|SPE2DB25FQL42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,406.92 firm fixed-price delivery order is for the supply of the medication LONSURF 20 MG-8.19 MG TABLET 20S. The contract has an ultimate completion date of May 19, 2025. AmerisourceBergen Drug Corp, a for-profit corporate entity, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $9,599.25 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 20 MG-8.19 MG TABLET 60S, a prescription medication, and has an ultimate completion date of August 16, 2024. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568189974 Sandostatin LAR Depot 10 mg kits. The contract has a firm fixed price of $2,030.13 and a completion date of May 9, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle....
  • SPE2DB24D2217
    Indefinite Delivery Contract
  • SPE2DB24D2217-SPE2DB24FJVRS
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LONSURF 20 MG-8.19 MG tablets. The contract has a firm fixed price of $8,531.96 and an ultimate completion date of September 19, 2024. This contract is not set aside for any particular business type. AmerisourceBergen, through its extensive federal contracting experience and supply chain capabilities, will provide these critical pharmaceutical products to support military treatment facilities and other federal healthcare providers. The DLA is a significant customer for AmerisourceBergen, with the company holding a large Indefinite Delivery Contract valued up to $999,999,999 through December 2025 to deliver a comprehensive range of medical commodities to the agency.

Generated 11/27/24, 9:08 AM